1998
DOI: 10.1046/j.1365-2443.1998.00196.x
|View full text |Cite
|
Sign up to set email alerts
|

Smad6 functions as an intracellular antagonist of some TGF‐β family members during Xenopus embryogenesis

Abstract: Background: Bone morphogenetic proteins (BMPs) transmit signals via the intracellular protein Smad1, which is phosphorylated by ligand bound receptors, translocates to the nucleus, and functions to activate BMP target genes. Recently, a subclass of Smad proteins has been shown to inhibit, rather than transduce, BMP signalling, either by binding to the intracellular domain of BMP receptors, thereby preventing phosphorylation-mediated activation of Smad1, or by binding directly to Smad1, thereby inhibiting its a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
63
0

Year Published

1998
1998
2007
2007

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 75 publications
(67 citation statements)
references
References 21 publications
4
63
0
Order By: Relevance
“…To confirm inhibiting BMP signaling during the later patterning of the renal field results in the malformation of the pronephric tubules and duct, but does not alter glomal tissue, we next took advantage of an additional inducible construct (ERSmad6) previously shown to conditionally inhibit BMP signaling in vivo (Nakayama et al, 1998;Ishisaki et al, 1999;Schmerer and Evans, 2003). Analogous to the ⌬Smad7 construct described above, another protein that specifically regulates BMP signaling is the Smad6 transcriptional cofactor.…”
Section: Conditional Regulation Of the Inhibitory-smad Smad6 Also Rmentioning
confidence: 99%
“…To confirm inhibiting BMP signaling during the later patterning of the renal field results in the malformation of the pronephric tubules and duct, but does not alter glomal tissue, we next took advantage of an additional inducible construct (ERSmad6) previously shown to conditionally inhibit BMP signaling in vivo (Nakayama et al, 1998;Ishisaki et al, 1999;Schmerer and Evans, 2003). Analogous to the ⌬Smad7 construct described above, another protein that specifically regulates BMP signaling is the Smad6 transcriptional cofactor.…”
Section: Conditional Regulation Of the Inhibitory-smad Smad6 Also Rmentioning
confidence: 99%
“…Three bone-inducing LMP variants (LMP-1, LMP1t, and LMP-3) each contain a unique 45-amino acid peptide sequence that includes two putative Smurf1 WW domain interaction sites (A and B) (Fig. 2a) (29). The WW domain-interacting sites are absent in the nonosteogenic LMP variant (LMP-2).…”
Section: Determination Of the Domains Of Lmp-1 And Smurf1 That Are Inmentioning
confidence: 99%
“…Recently, a distinct subgroup of distantly related Smads, including mammalian Smad6 (23) and Smad7 (24,25), Xenopus Smad6 (XSmad6) (26) and Smad8 (now called XSmad7) (27) and Drosophila Dad (28), have been identified as intracellular antagonists of TGF-␤ family signaling. Smad6 and Smad7 form stable associations with activated TGF-␤ type I receptor (T␤R-I), thereby preventing pathway restricted Smads from binding to, and being phosphorylated by, these receptors.…”
Section: Members Of the Transforming Growth Factor-␤ (Tgf-␤)mentioning
confidence: 99%
“…Smad6 has also been shown to bind to and inhibit signaling downstream of BMP receptors (23) and to prevent formation of an active Smad4/Smad1 signaling complex by directly competing with Smad4 for binding to Smad1 (29). In Xenopus embryos, ectopically expressed murine Smad7 (mSmad7), XSmad7, or XSmad6 can partially antagonize activin-like signaling although both are much more potent inhibitors of BMPs (25)(26)(27)29). Inhibitory Smads, like signal-transducing Smads, contain conserved N-and C-domains, but the function of each domain is unknown.…”
Section: Members Of the Transforming Growth Factor-␤ (Tgf-␤)mentioning
confidence: 99%